Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial    crawled time : 00:20    save search
FTFT DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Future FinTech Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FTFT
Published: 2024-03-16 (Crawled : 00:20) - prnewswire.com
EAF | $1.65 5.1% 0.0% 5.2M twitter stocktwits trandingview |
Producer Manufacturing
 | Email alert Add to watchlist
BCDRF | $4.978 -8.71% 100 twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
FTFT | $0.875 4.17% 4.0% 15K twitter stocktwits trandingview |
Consumer Non-Durables
 | Email alert Add to watchlist
SAN | $5.05 1.2% 0.0% 4.9M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
first deadline group trial
Midwest Energy Emissions Corp. Wins $57 Million Delaware Patent Infringement Verdict with Caldwell Cassady & Curry as Lead Trial Counsel
Published: 2024-03-02 (Crawled : 00:20) - prnewswire.com
MEEC | $0.78 20.7% 84K twitter stocktwits trandingview |
Administrative and Support and ...
 | Email alert Add to watchlist
AJG | News | $236.81 -0.45% 0.0% 610K twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
patent energy million trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mobileye Global Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MBLY
Published: 2024-02-17 (Crawled : 00:20) - prnewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MBLY | $31.12 2.27% 2.22% 3M twitter stocktwits trandingview |
| Email alert Add to watchlist
GDHG | $0.284 10.12% 9.19% 4.2M twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline global trial
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MSS
Published: 2024-02-17 (Crawled : 00:20) - prnewswire.com
MSS | $1.25 0.81% 14K twitter stocktwits trandingview |
| Email alert Add to watchlist
MBLY | $31.12 2.27% 2.22% 3M twitter stocktwits trandingview |
| Email alert Add to watchlist
GDHG | $0.284 10.12% 9.19% 4.2M twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline solutions trial
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
Published: 2024-02-10 (Crawled : 00:20) - prnewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
INSP | $234.19 0.11% 0.0% 260K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MRCY | News | $28.49 3.83% 3.69% 440K twitter stocktwits trandingview |
Electronic Technology
 | Email alert Add to watchlist
inspire deadline medical trial
4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD
Published: 2024-02-03 (Crawled : 00:20) - globenewswire.com
FDMT M | $24.255 -2.24% -2.29% 290K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
prism favorable positive trial
EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
Published: 2024-02-03 (Crawled : 00:20) - globenewswire.com
EYPT | News | $16.47 -6.26% -6.68% 1.1M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
eyp-1901 macular treatment pharmaceuticals topline trial
ROSEN, LEADING TRIAL ATTORNEYS, Encourages ChargePoint Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CHPT
Published: 2024-01-13 (Crawled : 00:20) - prnewswire.com
DRVN | $14.25 -5.32% -5.61% 1.4M twitter stocktwits trandingview |
| Email alert Add to watchlist
MSS | $1.25 0.81% 14K twitter stocktwits trandingview |
| Email alert Add to watchlist
CHPT 4 | $1.29 -3.73% 0.0% 9.6M twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Expensify, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EXFY
Published: 2024-01-13 (Crawled : 00:20) - prnewswire.com
EXFY S | $1.65 6.8% 6.36% 760K twitter stocktwits trandingview |
| Email alert Add to watchlist
DRVN | $14.25 -5.32% -5.61% 1.4M twitter stocktwits trandingview |
| Email alert Add to watchlist
CHPT 4 | $1.29 -3.73% 0.0% 9.6M twitter stocktwits trandingview |
| Email alert Add to watchlist
trusted deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DG
Published: 2023-12-16 (Crawled : 00:20) - prnewswire.com
DG 4 | $143.16 0.3% -0.08% 1.3M twitter stocktwits trandingview |
Retail Trade
 | Email alert Add to watchlist
ILMN | $122.74 -1.38% -1.4% 1.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
LICY | $0.6731 -5.48% 1.9% 2.4M twitter stocktwits trandingview |
| Email alert Add to watchlist
corporation deadline trial
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting
Published: 2023-12-09 (Crawled : 00:20) - globenewswire.com
FGEN | $0.9844 -8.0% -8.7% 2.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
anemia risk meeting trial
ROSEN, TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Published: 2023-11-11 (Crawled : 00:20) - prnewswire.com
LUMN | $1.29 -5.15% 0.0% 12M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
SCYX | $1.495 -3.55% -3.68% 88K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
DCGO | $3.52 0.57% 0.57% 470K twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DCGO
Published: 2023-11-11 (Crawled : 00:20) - prnewswire.com
LUMN | $1.29 -5.15% 0.0% 12M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
SCYX | $1.495 -3.55% -3.68% 88K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
DCGO | $3.52 0.57% 0.57% 470K twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
Replimune Presents Updated Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers During Oral Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Published: 2023-11-03 (Crawled : 00:20) - globenewswire.com
REPL | $6.32 -1.56% -1.58% 630K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation cancer cell immunotherapy meeting skin trial results
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Origin Materials, Inc. Investors with Losses to Secure Counsel Before Important October 24 Deadline in Securities Class Action - ORGN, ORGNW
Published: 2023-10-21 (Crawled : 00:20) - prnewswire.com
LAW 4 | $7.49 -3.11% 0.0% 410K twitter stocktwits trandingview |
| Email alert Add to watchlist
BCLYF | $2.31 -10.14% 1.7K twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
BCS | $9.6 -1.03% 0.0% 19M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
origin deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages KeyCorp Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KEY
Published: 2023-08-25 (Crawled : 00:20) - prnewswire.com
KEY | $14.93 1.43% 0.0% 15M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
BTAI | News | $2.7 -9.09% -10.0% 880K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ALDX | $3.93 0.51% 0.51% 570K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
deadline trial
One-Year Data from Phase 3 Trial of TransCon™ PTH in Adults with Hypoparathyroidism Presented at ENDO 2023
Published: 2023-06-17 (Crawled : 00:20) - globenewswire.com
ASND | $143.14 -1.17% -1.18% 230K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
trial
Ocular Therapeutix™ Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD
Published: 2023-06-10 (Crawled : 00:20) - globenewswire.com
OCUL | News | $4.645 -7.1% -7.64% 3.9M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ocular treatment ongoing topline trial
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
Published: 2023-06-03 (Crawled : 00:20) - globenewswire.com
EVAX | $4.06 -1.93% -1.97% 10K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
evx-01 melanoma vaccine cancer technology trial
HSAI FINAL DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Hesai Group Investors to Secure Counsel Before Important June 6 Deadline in Securities Class Action Filed by the Firm - HSAI
Published: 2023-06-03 (Crawled : 00:20) - prnewswire.com
RLMD | $3.85 -1.54% -1.56% 110K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
CGC | $8.96 14.14% 12.39% 7.4M twitter stocktwits trandingview |
Process Industries
 | Email alert Add to watchlist
HSAI | $4.275 0.83% 0.82% 260K twitter stocktwits trandingview |
n/a
 | Email alert Add to watchlist
deadline group trial
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.